Related Experiment Video
Updated: Aug 8, 2026

Ex Vivo Infection of Murine Epidermis with Herpes Simplex Virus Type 1
Published on: August 24, 2015
Biochemical characterization of herpes simplex virus type-1-immunostimulating complexes (ISCMOs): a
M Erturk1, R Jennings, R J Phillpotts
1Department of Virology, University of Sheffield Medical School, UK.
Insights
Researchers developed an immunostimulating complex (ISCOM) vaccine containing multiple herpes simplex virus type 1 (HSV-1) glycoproteins. This HSV-1 ISCOM preparation shows potential for human vaccination against HSV-1 infections.
Area of Science:
- Virology
- Immunology
- Vaccine Development
Background:
- Herpes simplex virus type 1 (HSV-1) poses significant public health challenges.
- Effective vaccines against HSV-1 are critically needed.
Purpose of the Study:
- To prepare and characterize an immunostimulating complex (ISCOM) containing multiple HSV-1 glycoproteins.
- To evaluate the potential of this HSV-1 ISCOM preparation as a human vaccine.
Main Methods:
- Extraction of HSV-1 antigens using zwitterionic detergent.
- Purification via gradient centrifugation.
- Characterization using enzyme-linked immunosorbent assay (ELISA), SDS-PAGE, and radioimmunoprecipitation.
- DNA content determination using 3H-thymidine labeling.
Main Results:
- The HSV-1 ISCOM preparation contained multiple HSV-1 glycoproteins (B, C, D, E, H, I) and other proteins.
- The protein and DNA content of the ISCOMs were quantified.
Conclusions:
- The characterized HSV-1 ISCOM preparation contains key HSV-1 glycoproteins.
- This preparation holds promise as a potential vaccine candidate for human use against HSV-1.
Abstract:
The preparation and characterization of an immunostimulating complex (ISCOM) preparation containing several HSV-1 glycoproteins, including the major glycoproteins B and D is described. The multi-glycoprotein HSV-1 ISCOM preparation was obtained from a gradient-purified aqueous HSV-1 antigen preparation following extraction from infected cells using a zwitterionic detergent. With polyclonal and monoclonal antibodies to HSV-1 glycoproteins in enzyme-linked immunosorbent assay, SDS-polyacrylamide gel electrophoresis and radioimmunoprecipitation techniques, the HSV-1 ISCOM preparation was shown to contain glycoproteins B, C, D, E, H and I, although further, additional proteins were also present. The DNA content of HSV-1 ISCOMs was determined using a 3H-thymidine labelling method. The protein and DNA contents of the HSV-1 ISCOM preparation are discussed with reference to the potentialities of the preparation as a vaccine for use in human beings.
More Related Videos
Related Concept Videos
Viral Structure
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Herpes
Genital Herpes
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly

